Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
NEURESCUE ApS
APS
Active
Advertising protection
CVR 35802185
Antonigade 11, 1106
København K
Manufacture of medical and dental instruments and supplies
·
NACE 3250
Est. 2014 · 12 years old
11 employees
www.neurescue.com
Monitor
Share
Denmark
/
Companies
/
Manufacture of medical and dental instruments and supplies
/
NEURESCUE ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-4M
-8M
-12M
-16M
2021: -2M
-2M
2021
2022: -2M (0% vs 2021)
-2M
0%
2022
2023: -3M (-50% vs 2022)
-3M
-50%
2023
2024: -8M (-167% vs 2023)
-8M
-167%
2024
2025: -13M (-62% vs 2024)
-13M
-62%
2025
EBITDA
DKK millions
0M
-6M
-12M
-19M
-25M
2021: -8M
-8M
2021
2022: -9M (-12% vs 2021)
-9M
-12%
2022
2023: -9M (0% vs 2022)
-9M
0%
2023
2024: -15M (-67% vs 2023)
-15M
-67%
2024
2025: -20M (-33% vs 2024)
-20M
-33%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
-12.538
-7.511
-2.530
-2.382
-2.314
Staff expenses
-7.341
-7.132
-6.828
-6.818
-5.751
EBITDA
-19.879
-14.643
-9.358
-9.200
-8.065
Depreciation & amort.
-21
-21
-21
-2
-0
EBIT
-19.900
-14.664
-9.378
-9.202
-8.065
Net financials
-35
-1.517
-1.086
-811
-850
Profit before tax
-19.935
-16.181
-10.464
-10.013
-8.915
Tax
-4.291
-3.269
-2.185
-2.208
-1.480
Net profit
-15.644
-12.912
-8.280
-7.805
-7.435
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
18.139
30.687
9.451
9.919
20.790
Equity
11.281
26.925
-14.441
-6.162
1.643
Long-term debt
491
474
7.434
444
14.436
Short-term debt
6.366
3.288
16.459
15.637
4.712
Total debt
6.858
3.762
23.892
16.081
19.147
Financial ratios
5-year trend
EBITDA margin (of gross profit)
<−999 %
This company
2021
2025
Equity ratio
62,2 %
This company
38,2 %
Market median
This company
Market median
63% above market
2021
2025
Return on equity
-138,7 %
This company
18,4 %
Market median
This company
Market median
854% below market
2021
2025
Net profit margin (of gross profit)
<−999 %
This company
2021
2025
Asset turnover (of gross profit)
-0,69×
This company
2021
2025
Debt / equity
0,61×
This company
0,62×
Market median
This company
Market median
2% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on NEURESCUE ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
